Cell-Free RNA Sequencing from Biofluid Samples
- 15 July 2023
- book chapter
- Published by Springer Nature
- Vol. 2695, 9-25
Abstract
Liquid biopsy has obvious advantages over invasive sampling methods. Cell-free DNA is now widely used in prenatal and cancer diagnosis. Cell-free RNA is relatively unstable but could contain potential biomarkers, and some studies have demonstrated that cfRNA sequencing may be developed to be a promising diagnostic assay for disease detection. In this chapter, we introduce a modified protocol for the detection of cfRNA based on next-generation sequencing (NGS). This protocol has been specifically optimized for low-input, fragmented cfRNA samples. Key words Liquid biopsy cfRNA sequencing Low-abundant RNA library construction cfRNA biomarkersKeywords
This publication has 8 references indexed in Scilit:
- A comprehensive characterization of the cell-free transcriptome reveals tissue- and subtype-specific biomarkers for cancer detectionNature Communications, 2021
- Charting Extracellular Transcriptomes in The Human Biofluid RNA AtlasCell Reports, 2020
- Circulating Cell-Free Nucleic Acids: Main Characteristics and Clinical ApplicationInternational Journal of Molecular Sciences, 2020
- Performance assessment of total RNA sequencing of human biofluids and extracellular vesiclesScientific Reports, 2019
- Large Differences in Small RNA Composition Between Human BiofluidsCell Reports, 2018
- Diversity and signature of small RNA in different bodily fluids using next generation sequencingBMC Genomics, 2018
- Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasmaProceedings of the National Academy of Sciences, 2011
- Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkersNature Cell Biology, 2008